Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MZE782 in Adults With Phenylketonuria (PKU)
NCT07694440Phase 2Recruiting
- Sponsor
- Maze Therapeutics
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Countries
- 3
01
Overview
A Phase 2 trial of MZE782 in phenylketonuria (PKU), sponsored by Maze Therapeutics. Started Jun 2026; status: recruiting.
02
Drugs
MZE782
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT07694440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07694440.